MX9304378A - Metodo de preparacion de derivados de carbamato defisostigmina a partir de eseretoles. - Google Patents

Metodo de preparacion de derivados de carbamato defisostigmina a partir de eseretoles.

Info

Publication number
MX9304378A
MX9304378A MX9304378A MX9304378A MX9304378A MX 9304378 A MX9304378 A MX 9304378A MX 9304378 A MX9304378 A MX 9304378A MX 9304378 A MX9304378 A MX 9304378A MX 9304378 A MX9304378 A MX 9304378A
Authority
MX
Mexico
Prior art keywords
formula
compound
eseretols
defisostigmine
preparation
Prior art date
Application number
MX9304378A
Other languages
English (en)
Inventor
George S K Wong
Thomas B K Lee
Franz Weiberth
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of MX9304378A publication Critical patent/MX9304378A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Esta solicitud se refiere a un nuevo procedimiento para preparar un producto de fórmula; el cual procedimiento comprende (a) poner en contacto un compuesto de fórmula II para proporcionar un compuesto de fórmula III (b) poner en contacto la mezcla de reacción que contiene el compuesto de fórmula III bien (1) con un isocianato de fórmula R1NCO y aislar un producto de fórmula I en donde R2 es hidrógeno; o bien (2) con un compuesto de fórmula IV para proporcionar un compuesto de fórmula V poner en contacto la mezcla de reacción que contiene el compuesto de fórmula V obteniendo en la etapa (b) con un compuesto de fórmula R1R2NH en donde R1 y R2 son como se definieron antes; y aislar el producto de fórmula I.
MX9304378A 1992-07-21 1993-07-20 Metodo de preparacion de derivados de carbamato defisostigmina a partir de eseretoles. MX9304378A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/918,337 US5302721A (en) 1992-07-21 1992-07-21 Method of preparation of physostigmine carbamate derivatives from eseretholes

Publications (1)

Publication Number Publication Date
MX9304378A true MX9304378A (es) 1994-03-31

Family

ID=25440209

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304378A MX9304378A (es) 1992-07-21 1993-07-20 Metodo de preparacion de derivados de carbamato defisostigmina a partir de eseretoles.

Country Status (17)

Country Link
US (2) US5302721A (es)
EP (1) EP0581107A1 (es)
JP (2) JP2656207B2 (es)
KR (1) KR940005628A (es)
CN (1) CN1039717C (es)
AU (1) AU657422B2 (es)
CA (1) CA2100909A1 (es)
CZ (1) CZ284561B6 (es)
FI (1) FI933263A (es)
HU (1) HUT68895A (es)
IL (1) IL106390A0 (es)
MX (1) MX9304378A (es)
NO (1) NO300635B1 (es)
NZ (1) NZ248179A (es)
PH (1) PH30149A (es)
RU (1) RU2108334C1 (es)
TW (1) TW297816B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US6133444A (en) * 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
DE69632324T2 (de) * 1995-06-07 2005-06-16 PerSeptive Biosystems, Inc., Framingham Pna-dna-chimäre und pna-synthone zu deren herstellung
US5665880A (en) * 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) * 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers
US6495700B1 (en) 2002-01-09 2002-12-17 Axonyx, Inc. Process for producing phenserine and its analog
CA2543322A1 (en) 2003-10-21 2005-05-12 Sention, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
JP4419518B2 (ja) * 2003-10-30 2010-02-24 アイシン精機株式会社 シートスライド装置
EP1779867A4 (en) * 2004-07-01 2009-12-02 Eisai R&D Man Co Ltd MEANS FOR PROMOTING NERVE REVENERATION
JP2010518010A (ja) * 2007-02-02 2010-05-27 コルシド・ファーマシューティカルズ・インコーポレイテッド コリンエステラーゼを阻害する化合物
WO2009011901A2 (en) * 2007-07-18 2009-01-22 Colucid Pharmaceuticals, Inc. Methods for promoting wakefulness
US8593728B2 (en) * 2009-02-19 2013-11-26 Toyota Motor Engineering & Manufacturing North America, Inc. Multilayer photonic structures
AU2009270830A1 (en) * 2008-07-16 2010-01-21 Colucid Pharmaceuticals, Inc. Stigmine conjugates for substance use disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE349887B (es) * 1971-02-10 1972-10-09 Asea Atom Ab
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use

Also Published As

Publication number Publication date
AU657422B2 (en) 1995-03-09
FI933263A (fi) 1994-01-22
RU2108334C1 (ru) 1998-04-10
KR940005628A (ko) 1994-03-22
IL106390A0 (en) 1993-11-15
TW297816B (es) 1997-02-11
NZ248179A (en) 1995-01-27
CZ145393A3 (en) 1994-03-16
HU9302108D0 (en) 1993-10-28
NO932615D0 (no) 1993-07-20
JPH06179677A (ja) 1994-06-28
AU4205093A (en) 1994-01-27
JP2656207B2 (ja) 1997-09-24
CA2100909A1 (en) 1994-01-22
FI933263A0 (fi) 1993-07-19
CZ284561B6 (cs) 1999-01-13
NO300635B1 (no) 1997-06-30
JP2843798B2 (ja) 1999-01-06
EP0581107A1 (en) 1994-02-02
US5302721A (en) 1994-04-12
CN1083816A (zh) 1994-03-16
JPH09165389A (ja) 1997-06-24
HUT68895A (en) 1995-08-28
PH30149A (en) 1997-01-21
CN1039717C (zh) 1998-09-09
NO932615L (no) 1994-01-24
US5455354A (en) 1995-10-03

Similar Documents

Publication Publication Date Title
MX9304378A (es) Metodo de preparacion de derivados de carbamato defisostigmina a partir de eseretoles.
ES2123066T3 (es) Procedimiento para sintetizar ceramidas que contienen fitoesfingosina y composiciones cosmeticas que las contienen.
DE69627381D1 (de) Vefahren zur herstellung von erythrmycinderivate
HU9302138D0 (en) Phenyl-imidazoline derivatives, pharmaceutical preparatives containing them as active substance and methods for producing said compounds and preparatives
ATE317912T1 (de) Verfahren zur herstellung von beta-lactamen
DE69823662D1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
PL251603A1 (en) Method of obtaining novel substituted 5,11-dihydro-6h-dibenz b,e azepin-6-ones
MX9304397A (es) Metodo de preparacion de derivados de carbamato de disoestigmina a partir de fisoestigmina.
ATE298325T1 (de) Verfahren zur herstellung von n-(4-hydroxyphenyl)-n'-(4'-aminophenyl)-piperaz ne
ATE61571T1 (de) Aromatische polyisocyanate, verfahren zu ihrer herstellung sowie ihre verwendung als klebstoffkomponente.
ATE229006T1 (de) Verfahren zur herstellung von schwefelhaltigen imidazolderivaten und erhaltene zwischenprodukte
HUP9801720A2 (hu) Új eljárás palatinit előállítására
AR009300A1 (es) Procedimiento para la preparacion de derivados de carbamato de fisostigmina a partir de eseretoles y procedimiento de obtencion de un intermediario endicho procedimiento
ATE176783T1 (de) Verfahren zur herstellung von urethangruppen enthaltende bisoxazolidinen
ATE256108T1 (de) Verfahren zur herstellung von cholecalciferol- derivaten und zwischenverbindungen
DE59004015D1 (de) Verfahren zur Herstellung von Polyurethanpulvern.
DE60014103D1 (de) Verfahren zur herstellung von debromohymenialdisin und deren analogen
DE69707603D1 (de) Verfahren zur Herstellung von N2-Arylsulfonyl-L-Argininamiden
HK1027560A1 (en) Method for producing 1,3-disubstituted 2-nitroguanidines
ES2071177T3 (es) Derivados substituidos de amidas de aminoacido, su obtencion y empleo.
EP0106282A3 (en) Production of caerulein intermediate
EA199700300A1 (ru) СПОСОБ ПОЛУЧЕНИЯ ПРАКТИЧЕСКИ ЧИСТЫХ ИЗОМЕРОВ α-БИСОКСИМОВ
KR840008650A (ko) 폴리사이클릭 카복실산 화합물의 제조방법
ATE319849T1 (de) Verfahren zur herstellung vom ampicillin
DE59607280D1 (de) Verwendung von aminoalkoholderivaten als arzneimittel, derivate sowie verfahren zu deren herstellung

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees